CURADEL SURGICAL INNOVATIONS, INC.

Bonita Springs, FL · CIK 0001976619 · Biotech · Private

Zwitterionic compounds for targeted alpha therapy delivery

curadelpharma.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$24M
3 Form D · Oct 2025
12 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$1,999,991
Private capital raisedForm D · SEC$7,500,052
Private capital raisedForm D · SEC$14,479,902
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2463Verseon Corp—$25M
2464Pharmazz, Inc.—$25M
2465Abzena plc—$4.3M
2466CURADEL SURGICAL INNOVATIONS, INC.—$24M
2467Vaxart, Inc.—$23M
2468PULMOTECT, INC—$22M
2469New Echota Biotechnology——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 6 related persons
  • GAREN BOHLINDirector
  • WALID FAKHRYDirector
  • John Frangioni, M.D., Ph.D.Director · Executive Officer
  • JOHN FRANGIONI M.D., PH.D.Director · Executive Officer
  • MARC GARNICKDirector
  • HENRY KAYDirector

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.